Status:

COMPLETED

Counterregulatory Hormone Production in Adrenal Insufficiency and Diabetes Type I

Lead Sponsor:

University of Wuerzburg

Conditions:

Addison's Disease

Adrenal Insufficiency

Eligibility:

All Genders

18-65 years

Brief Summary

Patients with adrenal insufficiency also exhibit an adrenomedullary dysfunction. Furthermore, patients who suffer from both, adrenal insufficiency and type I diabetes more frequently report hypoglycem...

Detailed Description

As patients with adrenal insufficiency also exhibit an adrenomedullary dysfunction and patients who suffer from both, adrenal insufficiency and type I diabetes more frequently report hypoglycemia, par...

Eligibility Criteria

Inclusion

  • Diagnosis of Addison's disease and/or diabetes mellitus type I or healthy control with normal adrenal function and normal glucose regulation
  • Age ≥ 18 years
  • Ability to comply with the study protocol
  • Capability to perform spiroergometry

Exclusion

  • Any contraindication for performing spiroergometry according to the guidelines of the German Cardiac Society:
  • acute myocardial infarction
  • instable angina pectoris
  • symptomatic arrhythmia
  • severe and symptomatic stenosis of the aortic valve
  • decompensated heart failure
  • acute pulmonary embolism
  • Acute myocarditis
  • Acute pericarditis
  • Acute aortic dissection
  • main coronary artery disease
  • valvulopathies
  • electrolyte disturbance
  • arterial hypertension (systolic blood pressure \> 200 mm Hg, diastolic BP \> 110 mm Hg)
  • Tachyarrhythmia or Bradyarrhythmia
  • Hypertrophic cardiomyopathy and other forms of obstructive heart disease
  • second or third degree atrioventricular block
  • Fever
  • Diabetes mellitus Type 2
  • Diseases or medication influencing the endogenous levels of plasma catecholamines(e. g. pheochromocytoma, paraganglioma, antidepressants, levodopa)
  • Glucocorticoid-pharmacotherapy

Key Trial Info

Start Date :

March 1 2011

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 1 2013

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT01452893

Start Date

March 1 2011

End Date

December 1 2013

Last Update

January 6 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Dept. of Endocrinology and Diabetology, Dept. of Medicine I, University Hospital Wuerzburg

Würzburg, Germany, 97080